U.S. Markets closed

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
250.92+8.38 (+3.46%)
At close: 04:00PM EDT
250.00 -0.92 (-0.37%)
After hours: 07:16PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close242.54
Bid241.27 x 1000
Ask250.75 x 800
Day's Range243.23 - 251.26
52 Week Range229.40 - 277.29
Avg. Volume1,163,341
Market Cap71.523B
Beta (5Y Monthly)0.65
PE Ratio (TTM)36.63
EPS (TTM)6.85
Earnings DateFeb 02, 2022 - Feb 07, 2022
Forward Dividend & Yield3.48 (1.40%)
Ex-Dividend DateJun 08, 2022
1y Target Est284.25

    Treat Becton, Dickinson and Company With Care

    Becton, Dickinson is a medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BDX's fundamental rating was just raised by a sell-side firm to "Overweight" with a $275 price target.

  • Zacks

    BD (BDX) Integrates Innovative Solution to Boost Patient Care

    BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.

  • PR Newswire

    BD Announces Voluntary Recall on Intraosseous Products

    BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ Intraosseous Needle Set Kits, BD™ Intraosseous Manual Driver Kits and BD™ Intraosseous Powered Drivers.